| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0074 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |